Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Chuan Qin(Tongji Hospital), Dai‐Shi Tian(Tongji Hospital), Ziwei Hu(Tongji Hospital), Ke Ma(Tongji Hospital), Cuihong Xie(Tongji Hospital), Tao Yu(Shanghai Jiao Tong University), Ke Shang(Tongji Hospital), Wei Wang(Central South University), Shuoqi Zhang(Tongji Hospital), Sheng Yang(Fujian Medical University), Luo‐Qi Zhou(Tongji Hospital)
Cited by 963
Related Papers
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
|Clinical Infectious Diseases|2020|5k
Lactate metabolism in human health and disease
|Signal Transduction and Targeted Therapy|2022|1.4k
CRISPR/Cas9 therapeutics: progress and prospects
|Signal Transduction and Targeted Therapy|2023|706
Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release
|Nature Medicine|2011|253
Chemokine CCL2–CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus
|Journal of Neuroscience|2017|214